| SBRVX | VRTIX | SBRVX / VRTIX | |
| Total Expense Ratio | 1.14 | 0.07 | 1,629% |
| Annual Report Gross Expense Ratio | 1.22 | 0.07 | 1,743% |
| Fund Existence | 6 years | 15 years | - |
| Gain YTD | 5.724 | 16.812 | 34% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 401M | 14.3B | 3% |
| Annual Yield % from dividends | 0.88 | 1.17 | 75% |
| Returns for 1 year | -0.89 | 8.63 | -10% |
| Returns for 3 years | 25.46 | 44.22 | 58% |
| Returns for 5 years | 24.65 | 37.86 | 65% |
| Returns for 10 years | N/A | 142.59 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ARP | 32.15 | 0.23 | +0.72% |
| PMV Adaptive Risk Parity ETF | |||
| DAPR | 39.17 | 0.04 | +0.10% |
| FT Vest US Equity Dp Bffr ETF Apr | |||
| FBT | 210.22 | -0.11 | -0.05% |
| First Trust NYSE Arca Biotech ETF | |||
| LCDL | 4.91 | -0.11 | -2.22% |
| GraniteShares 2x Long LCID Daily ETF | |||
| BMAX | 23.51 | -0.91 | -3.74% |
| Rex Bitcoin Corporate Treasury Convertible Bond ETF | |||